MARSHALL WACE, LLP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 45 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$374,558
-85.9%
214,033
-65.6%
0.00%
-83.3%
Q4 2022$2,647,182
+1485.1%
622,866
+342.8%
0.01%
Q3 2022$167,000140,6600.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders